Kopczyński Z, Stachowicz A, Kociałkowski K, Grodecka-Gazdecka S
Zakładu Analityki Medycznej i Oddziału Chirurgii, Katedry Onkologii Akademii Medycznej im. Karola Marcinkowskiego w Poznaniu.
Ginekol Pol. 1993 Feb;64(2):87-92.
The aim of the present study was to evaluate the diagnostic value of the new tumour marker MCA in serum from women with breast cancer. Relationship between presence MCA in serum and cER, cPgR, nER, nPgR in aqueous extracts from cancer tissues was subject of our investigation, too. Immunoenzymatic method (Roche) which employed monoclonal antibody MAb b-12 was used for determination of MCA in serum 49 operable patients (preoperative determination). In a group of 26 cancer patients MCA and cER, cPgR, nER, nPgR were tested simultaneously. Steroid hormone receptors were measured by immunoenzymatic method (Abbott). Mean concentration of MCA in women with breast cancer (n = 36) was higher as compared with control (n = 21, p < 0.001). When 6.86 U/ml was took as mean level of MCA in control group it was found that 46% women with benign tumours, 64% with carcinoma ductal and 62% with carcinoma lobular have had concentrations of MCA below this value. Also it was found that differences between mean levels of MCA and cER, cPgR, nER, nPgR were statistical significance only in women with carcinoma ductal. On the basis of our own investigations we can suggest that MCA has limited value in the diagnosis of breast cancer.
本研究的目的是评估新型肿瘤标志物MCA在乳腺癌女性患者血清中的诊断价值。血清中MCA的存在与癌组织水提取物中的cER、cPgR、nER、nPgR之间的关系也是我们研究的对象。采用单克隆抗体MAb b - 12的免疫酶法(罗氏公司)用于测定49例可手术患者血清中的MCA(术前测定)。在一组26例癌症患者中,同时检测了MCA和cER、cPgR、nER、nPgR。类固醇激素受体采用免疫酶法(雅培公司)测定。乳腺癌女性患者(n = 36)的MCA平均浓度高于对照组(n = 21,p < 0.001)。当以6.86 U/ml作为对照组MCA的平均水平时,发现46%的良性肿瘤女性、64%的导管癌女性和62%的小叶癌女性的MCA浓度低于该值。还发现,仅在导管癌女性中,MCA与cER、cPgR、nER、nPgR的平均水平差异具有统计学意义。基于我们自己的研究,我们可以认为MCA在乳腺癌诊断中的价值有限。